Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. by Jiefeng Zhao (9090305)

Subjects:

Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Frontier analysis for the potential for improvement in reducing the burden of IBD among WCBA across 204 countries and regions. by Jiefeng Zhao (9090305)

Subjects:

Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by Urbanization in the United States. by Zian Zafar Cheema (22446246)

Subjects:

Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by Census Regions in the United States. by Zian Zafar Cheema (22446246)

Subjects:

Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by the Overall population and Sex in the United States. by Zian Zafar Cheema (22446246)

Subjects:

Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by the Racial groups in the United States. by Zian Zafar Cheema (22446246)

Subjects:

Table 1_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

Table 2_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

SWFT scores and Lactate Levels. by Burhan Demirkıran (21601740)

Subjects:

The weekly content of the 8-week training program. by Burhan Demirkıran (21601740)

Subjects:

HRV Values. by Burhan Demirkıran (21601740)

Subjects:

Changes in subcutaneous fat thickness and muscle mass (Approximately here). by Burhan Demirkıran (21601740)

Subjects:

HRV values (Approximately here). by Burhan Demirkıran (21601740)

Subjects:

Trial Design (Approximately Here). by Burhan Demirkıran (21601740)

Subjects:

Supplementary Figure. by Burhan Demirkıran (21601740)

Subjects: